Rating History for Recursion Pharmaceuticals (RXRX ) by Morgan Stanley

More Stocks Rated by Morgan Stanley | Latest Ratings for RXRX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/16/2026 Sean Laaman Maintain Equalweight
(N/A)		 5.90
(5.30)		  
 		   Details